Tilray Brands is trading at $3.41, down 5.01%, after its October 8 fiscal Q1 revenue missed estimates and its loss was wider than expected. - Revenue was $257.1 million, up 23% year over year; the $0.32-per-share loss exceeded expectations, and cannabis revenue declined. - Management reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million. - Same-day coverage linked weakness to the miss and cannabis contraction. Broader markets and consumer staples rose modestly October 9, offering no stronger explanation.